KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) FCF Margin (2016 - 2025)

AbbVie (ABBV) has disclosed FCF Margin for 14 consecutive years, with 29.42% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 1532.0% to 29.42% in Q4 2025 year-over-year; TTM through Dec 2025 was 29.13%, a 252.0% decrease, with the full-year FY2025 number at 29.13%, down 252.0% from a year prior.
  • FCF Margin was 29.42% for Q4 2025 at AbbVie, down from 42.11% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 53.81% in Q3 2021 to a low of 10.49% in Q1 2025.
  • A 5-year average of 36.2% and a median of 34.35% in 2021 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: crashed -3025bps in 2024, then surged 1763bps in 2025.
  • AbbVie's FCF Margin stood at 32.84% in 2021, then surged by 45bps to 47.72% in 2022, then plummeted by -33bps to 31.8% in 2023, then surged by 41bps to 44.74% in 2024, then tumbled by -34bps to 29.42% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's FCF Margin are 29.42% (Q4 2025), 42.11% (Q3 2025), and 31.67% (Q2 2025).